Hypersomnolence Disorder

2

Review clinical trials related to Hypersomnolence Disorder. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access. Visit sanfordresearch.org/CoRDS to enroll.

Participants needed: 20,000
Trial details
Biological sex: AllType: ObservationalSponsor: Sanford HealthUpdated: May 29, 2025Locations: 2Duration: 100 Years
Eligibility criteria

Diagnosis of a rare disease, a disease of unknown prevalence, undiagnosed or an...

Diagnosis of a disease which is not rare

Status: Recruiting

International Swiss Primary Hypersomnolence and Narcolepsy Cohort Study

Swiss Primary Hypersomnolence and Narcolepsy Cohort Study (SPHYNCS) is a cohort study on disease presentation and long-term course with an exploratory approach to detect biomarkers.

Participants needed: 600
Trial details
Age: 10-70Biological sex: AllType: ObservationalSponsor: Insel Gruppe AG, University Hospital BernUpdated: Apr 20, 2023Locations: 1Duration: 36 Months
Eligibility criteria

Subjective complaints of Excessive daytime sleepiness (EDS) and/or Hypersomnia (... [+16]

Apnea index (AI) > 10 if on OSA treatment or untreated; or [+21]